Medical Technologies (MedTech) stories
Clinical trials in Australia and the United States will be accelerated as the Sydney start-up readies its labour monitor for regulators.
Life sciences firms could avoid costly FDA review delays as the software flags conflicting claims across filings before submissions are sent.
Rising US and Asia-Pacific demand lifted first-quarter revenue 22% at SOPHiA GENETICS, as genomic analyses hit a record 108,000.
Adoption is rising as customers report faster fixes and lower running costs, with one college cutting troubleshooting time by 90%.
The cornerstone commitment should help Longwall Ventures reach a GBP £100 million close and back more UK deep tech start-ups.
The new site will create 85 jobs and boost Ireland's role in high-value cardiac software as Medtronic expands digital health work in Galway.
Hospitals can now extend duress alerts and patient monitoring beyond wards as CenTrak adds AI reporting and low-cost BLE tags to its RTLS platform.
The grants are set to speed the rollout of AI tools across healthcare, manufacturing and finance, helping GTA firms reach market sooner.
Ireland's investor appeal held up even as European foreign direct investment fell 7% to a decade low, EY found.
A £10,000 grant and mentoring package could help speed MRI scans by up to 90%, easing diagnosis delays for hospitals and patients.
Community clinics and pharmacies could see more ear and hearing checks after government-backed funding for TympaHealth's AI-guided platform.
Registrations rose 60% on the previous edition as student teams turned ideas into prototypes judged by industry figures at the Mysuru final.
The award gives each student EUR €2,500 plus mentoring and placements, extending a five-decade partnership between the university and Stryker.
Underserved Indian communities could gain easier access to early screening as the platform links symptom checks with more than 30 kiosk tests.
Healthtech startups are finding it harder to scale as weaker exits and tighter liquidity help drive Canadian VC investment down to CAD $1 billion in 2025.
The AUD $490 million Waterloo precinct is set to ease Sydney’s lab space shortage as it moves into delivery with major global partners.
The funding could help turn hospital infusions into self-injectable treatments, as the London-founded firm scales microgravity drug crystallisation.
App-based marketplaces and telehealth tools are easing Australia’s doctor shortage, giving locums more control while improving care in remote areas.
A record CAD $1.52 million finale in Vancouver underlined growing support for women founders as three businesses shared the top prize.
Early demand for Nosebuds has been reinforced by Gold and Red Dot honours, boosting Goodair’s bid to scale its drug-free breathing device.